Most medical-tourism sites tell you their destination wins. This page tells you where each one is genuinely strong, where it is weak, and what you should verify before you pay anyone. China figures are our published partner-hospital all-in ranges; other markets are described qualitatively, because their pricing varies too much clinic-to-clinic to print a number you can rely on.
Weighing US waitlists, Turkey, India, Korea, or China? Here's the honest comparison. China figures are our published partner-hospital all-in ranges, verified 2025–2026; other markets are characterized qualitatively, because their pricing varies too much clinic-to-clinic to print a number you can rely on.
| Your option | The honest trade-off | Cost reality (typical) | What Verified China Care changes |
|---|---|---|---|
| Stay in the US | Waitlists measured in months, coverage denials, or full self-pay — even with insurance, deductibles and exclusions pile up. | CAR-T $500,000+ · knee/hip $30,000–50,000 · dental implants $40,000–60,000 | The same treatments at JCI-accredited Chinese teaching hospitals — CAR-T $89,000–170,000 · knee/hip $8,000–15,000 · dental $12,000–18,000, quoted all-in before you commit. |
| Turkey | Excellent for dental and aesthetics — but thin on advanced oncology, stem-cell programs, and complex orthopedics. Licensing and quality vary sharply clinic-to-clinic. | Dental-focused market; prices vary widely by clinic | One network covering dental and oncology, stem cell, cardiac, and orthopedics — JCI teaching hospitals with published tables, not per-clinic quotes. |
| India | Real value in cardiac and orthopedics — but accreditation and quality vary widely by facility, and published all-in pricing is still rare. | Value pricing; quality varies widely by facility | JCI-accredited teaching hospitals, written all-in pricing, published all-in pricing — the accountability layer most of the market lacks. |
| South Korea | World-class aesthetics, dermatology, and screening — at premium pricing, with limited depth in advanced oncology and regenerative programs. | Premium pricing | Advanced oncology, stem cell, and orthopedics at up to 80% below US self-pay — with direct payment at a written price on top. |
| China — with the right structure the option that answers all of the above | The medicine was never the risk. Opaque pricing and unaccountable middlemen were. | CAR-T $89,000–170,000 · stem cell $23,000–39,000 · knee/hip $8,000–15,000 · dental $12,000–18,000 · checkup $400–2,500 | Named JCI-accredited hospitals · published all-in tables · 100% paid to the hospital at the price fixed in writing · US LLC merchant of record · $0 upfront. |
About these figures: every China number above is the same verified all-in range from our cost table — nothing inflated for comparison. US figures are the published US self-pay benchmarks. Turkey, India, and Korea are characterized qualitatively because their pricing is clinic-dependent; we'd rather you compare apples to published apples. Full methodology & named hospitals →
Your money never touches China until treatment starts.
No invented testimonials — just the structure every case follows. We publish line-item quotes, a written price for every stage, and document outcomes against the treatment agreement.
Line-item quote within 48h. Send your records, a physician reviews eligibility, and you get an itemized quote: hospital, physician, medications, nursing, room, translation, and coordination — no surprise line items.
Every price fixed in writing. You pay the treating hospital directly at the price fixed in writing. If care isn't delivered as agreed, our coordination fee is refunded.
Outcomes documented, not promised. Your treatment plan and milestones are written into the agreement. We publish real outcomes only with patient consent, linked to verified case files — no fabricated reviews, ever.
Send your records and a physician reviews eligibility. You get an itemised all-in quote within 48 hours, with no deposit to start.